The global penile implants market is witnessing significant growth over the past few years backed by rising incidences of erectile dysfunction among men worldwide. Penile implants, also known as penile prosthesis, are medical devices that are surgically implanted inside the penis to treat erectile dysfunction or impotence. The implants allow men to attain and sustain an erection whenever they are sexually aroused. Common types of penile implants include malleable and inflatable penile implants. Malleable implants consist of semirigid yet bendable rods surgically implanted into the penis, while inflatable implants comprise inflatable cylinders that are pump-operated and can produce a natural-looking erection.
The penile implants market is estimated to be valued at USD 271.4 Mn in 2024 and is expected to reach USD 317.2 Mn by 2031, growing at a compound annual growth rate (CAGR) of 2.2% from 2024 to 2031.
Key Takeaways
Key players operating in the penile implants market are American Medical Systems, Coloplast, Boston Scientific Corporation, and Zephyr Surgical Implants.
The growing prevalence of erectile dysfunction across the world due to increasing prevalence of chronic lifestyle conditions like obesity and diabetes as well as rising awareness regarding treatment options is fueling demand for penile implants. According to a report by the Massachusetts Male Aging Study, nearly 50% of men aged 40-70 suffer from some degree of erectile dysfunction.
Major players in the Penile Implants Market are focusing on expanding their business globally backed by the untapped growth opportunities in emerging economies of Asia Pacific and Latin America. Additionally, the launch of advanced penile implant devices with bigger size options and inflatable features is helping companies strengthen their market presence.
Market drivers
One of the key drivers for the penile implants market is the growing number of men opting for penile implants as a permanent treatment solution for erectile dysfunction. While oral medications like sildenafil (Viagra) have been the first line treatment for decades, nearly 35% of patients do not achieve satisfactory results from such drugs. This has prompted more patients to consider penile implant surgery as an alternative treatment option. Moreover, recent product advancements with three-piece inflatable implants offering natural erection have increased patient acceptance for penile implant procedures.
The current geopolitical situation is impacting the growth of the penile implants market in various ways. With rising political tensions and economic uncertainties across many parts of the world, healthcare budgets are coming under increasing pressure. This has led to cost-containment measures and pricing pressures being exerted on medical device producers. Manufacturers of penile implants will need to focus on developing more affordable product options to expand access and counter budgetary challenges faced by healthcare systems. They must also strengthen their supply chain resilience and find alternative sourcing routes to mitigate risks arising from trade disruptions or sanctions.
Adopting a more globalized and diversified business strategy will help companies withstand geopolitical instability better. Partnerships with local players can aid market penetration in territories where direct presence may no longer be viable. Furthermore, compiling regional usage data and customizing products to specific cultural needs will boost adoption. A continued emphasis on enhancing device functionality, safety and patient comfort through technological innovation remains important to drive the market despite short-term hurdles.
In terms of geographical concentration, North America currently accounts for the largest share of the global penile implants market value-wise. This can be attributed to factors like favourable reimbursement policies, growing awareness about treatment options, and easy availability of advanced products. Asia Pacific is poised to be the fastest expanding regional market during the forecast period due to a rising prevalence of erectile dysfunction in populations across China, Japan and India combined with increasing medical tourism. Other emerging territories in the Middle East, Latin America and Africa also present substantial untapped opportunities for long-term market growth.
The penile implants market is anticipated to exhibit steady expansion over the next few years backed by favorable macroeconomic determinants like a growing elderly populace afflicted with age-related sexual health issues, rising income levels in developing nations enhancing access, and continued innovation leading to improved treatment outcomes and patient experience. However, the lingering effects of the Covid-19 pandemic coupled with geopolitical and economic headwinds pose near-term challenges for industry players to manage and navigate strategically. Concerted efforts towards removing barriers to care, expanding population coverage and prioritizing patient needs will be critical enablers for the market to realize its full potential over the forecast period.
Get More Insights on- penile implants market
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)